Carregant...
Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
BACKGROUND: Kidney transplant recipients (KTRs) receiving the mammalian target of rapamycin inhibitor sirolimus may display a reduced risk of skin cancer development compared to KTRs receiving calcineurin inhibitors. Despite studies investigating the effects of these 2 drug classes on T cells in pat...
Guardat en:
| Publicat a: | Transplant Direct |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5498012/ https://ncbi.nlm.nih.gov/pubmed/28706974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000694 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|